OSI accepts Astellas's sweetened $4 billion offer
May 16, 2010 at 22:16 PM EDT
Japanese drug maker Astellas signs a definitive agreement to acquire U.S. rival OSI Pharmaceuticals in a sweetened all-cash offer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.